4Filing Date: Sep 14, 2026
TransMedics (TMDX)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0001193125-26-390650
Total Value$109.1K
Trades1
Insiders1
Transaction Details
Weill David
Director·Direct
Buy · Acquire
Common Stock
Shares+1.34K
Price$81.63
Total Value$109.1K
Shares Owned After16.39K
Transaction DateSep 11, 2026
Post-Transaction Holdings
Weill David · Director
| Security | Shares | Change |
|---|---|---|
| Common Stock | 16.39K | +1.34K (8.87%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-09-11
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
--- Reporting Owner ---
Name: Weill David
CIK: 0001774270
Role: Director
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-09-11 | Code: P (Open market purchase)
Shares: +1,336 | Price: $81.63
Total Value: $109,057.68
Shares Owned After: 16,392 | Ownership: D (Direct)
--- Signature ---
/s/ By: /s/ Matthew S. Forsyth, Attorney-in-Fact (2026-09-14)